Founded in 2022, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation. ImmunAdd develops next generation saponin adjuvants and uses them as the basis for new combinations of adjuvants and adjuvanted vaccines to improve the efficacy and durability of vaccines.
Location: Taiwan, Taipei
Investors 1
| Date | Name | Website |
| - | Diamond Bi... | diamondbio... |